LINC02613

Across TCGA pan-cancer cohorts, LINC02613 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02613 data layer compared with 2 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02613 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02613 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCS show a favorable association.

ACC, LUAD, and UCEC are the cancer types where LINC02613 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.259	0.659	<.001	83	view →
LUAD	OS	Quartile	All	0.866	0.713	<.001	58	view →
UCEC	OS	Tertile	All	0.591	0.734	<.001	56	view →
LGG	OS	Median	All	0.355	0.502	<.001	41	view →
UCS	DFS	Quartile	III,IV	0.859	0.314	<.001	40	view →
ESCA	DFS	Quartile	III,IV	0.600	0.246	.003	27	view →
KIRP	DFS	Quartile	II,III,IV	0.789	0.117	.002	27	view →
KIRC	OS	Tertile	All	0.541	0.699	.012	22	view →
LIHC	OS	Median	All	0.710	0.853	.001	20	view →
LUSC	OS	Median	III,IV	0.791	0.535	.004	17	view →
BRCA	OS	Median	All	0.637	0.523	.005	12	view →
MESO	DFS	Quartile	All	0.270	0.679	.026	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02613–ACC (DFS)

Open the ACC breakdown →